AOBLX
Price
$14.59
Change
+$0.19 (+1.32%)
Updated
Aug 4 closing price
Net Assets
496.85M
CLBAX
Price
$41.04
Change
+$0.48 (+1.18%)
Updated
Aug 4 closing price
Net Assets
288.09B
Interact to see
Advertisement

AOBLX vs CLBAX

AOBLX vs CLBAX Comparison Chart in %
View a ticker or compare two or three
VS
AOBLX vs. CLBAX commentary
Aug 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AOBLX is a Buy and CLBAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBAX has more cash in the bank: 288B vs. AOBLX (497M). CLBAX pays higher dividends than AOBLX: CLBAX (1.82) vs AOBLX (1.60). AOBLX was incepted earlier than CLBAX: AOBLX (35 years) vs CLBAX (24 years). AOBLX (0.93) is less costly to investors than CLBAX (0.58). CLBAX is a more actively managed with annual turnover of: 50.00 vs. AOBLX (29.00). CLBAX initial investment is less costly to investors than AOBLX (2%) vs AOBLX (2%). CLBAX has a lower initial minimum investment than AOBLX: CLBAX (250) vs AOBLX (2500). AOBLX annual gain was more profitable for investors over the last year : 25.09 vs. CLBAX (12.85). AOBLX return over 5 years is better than : 38.80 vs. CLBAX (36.12).
AOBLXCLBAXAOBLX / CLBAX
Total Expense Ratio0.930.58160%
Annual Report Gross Expense Ratio0.930.58160%
Fund Existence35 years24 years-
Gain YTD14.35310.340139%
Front Load2%4%64%
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets497M288B0%
Annual Yield % from dividends1.601.8288%
Returns for 1 year25.0912.85195%
Returns for 3 years55.3242.71130%
Returns for 5 years38.8036.12107%
Returns for 10 years88.2795.4992%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TAYD53.701.20
+2.29%
Taylor Devices
HMC30.120.52
+1.76%
Honda Motor Co Ltd
BZH33.310.34
+1.03%
Beazer Homes USA
BOX31.760.06
+0.19%
BOX
KPRX2.47-0.12
-4.63%
Kiora Pharmaceuticals Inc.